V
Violeta Mavcutko
Publications - 2
Citations - 167
Violeta Mavcutko is an academic researcher. The author has contributed to research in topics: Antibiotic resistance & Epidemiology. The author has an hindex of 1, co-authored 1 publications receiving 113 citations.
Papers
More filters
Journal ArticleDOI
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.
Simon R. Harris,Michelle J Cole,Gianfranco Spiteri,Leonor Sánchez-Busó,Daniel Golparian,Susanne Jacobsson,Richard Goater,Khalil Abudahab,Corin Yeats,Béatrice Berçot,Maria José Borrego,Brendan Crowley,Paola Stefanelli,Francesco Tripodo,Raquel Abad,David M. Aanensen,David M. Aanensen,Magnus Unemo,Jacinta Azevedo,Eszter Balla,Christopher Barbara,Thea Bergheim,Viviane Bremer,Susanne Buder,Panayiota Maikanti-Charalambous,Stephanie A. Chisholm,Susan Cowan,Tania Crucitti,Mercedes Diez,Maria Dudas,Kirstine Eastick,Agathe Goubard,Maria Haller,Guôrún Svanborg Hauksdóttir,Steen Hoffmann,Gwenda Hughes,Derval Igoe,Samo Jeverica,Irena Klavs,Hilde Kløvstad,Peter Kohl,Vasileia Konte,Ineke Linde,Violeta Mavcutko,Jackie M. Melillo,Gatis Pakarna,Peter Pavlik,Despo Pieridou,Guy La Ruche,Guôrún Sigmundsdóttir,Soteroulla Soteriou,Angelika Stary,Barbara Suligoi,Peter Truska,Eva Tzelepi,Birgit Van Benthem,Alje P. van Dam,Julio A. Vázquez,Inga Velicko,Ruth Verbrugge +59 more
TL;DR: This work provides the first use of joint analysis of WGS and epidemiological data in an international programme for regional surveillance of sexually transmitted infections and provides a framework for genomic surveillance of gonococci through standardised sampling, use of W GS, and a shared information architecture for interpretation and dissemination.
Journal ArticleDOI
Significant increase in azithromycin “resistance” and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019
Michaela Day,Susanne Jacobsson,Gianfranco Spiteri,Carina Kulishev,Noshin Sajedi,Neil Woodford,Benjamin Blumel,Marieke J. van der Werf,Andrew J Amato-Gauci,Michelle J Cole,C. Eder,Sonja Pleininger,Steliana Huhlescu,Irith De Baetselier,Blaženka Hunjak,Tatjana Nemeth Blažić,Panagiota Maikanti-Charalampous,Despo Pieridou,Hana Zákoucká,Helena Žemličková,Steen Hoffmann,Susan Cowan,R. Peetso,Jelena Viktorova,Ndeindo Ndeikoundam,Béatrice Berçot,Anu Patari Sampo,V. Kirjavainen,Susanne Buder,Klaus Jansen,Vivi Miriagou,Eszter Balla,Maria E. Dudas,Gudrun Sigmundsdottir,Lena Rós Ásmundsdóttir,Sinéad Saab,Brendan M. Crowley,Anna Carannante,Paola Stefanelli,Gatis Pakarna,Violeta Mavcutko,Robert Cassar,Christopher Barbara,F. Vella,Alje P. van Dam,Ineke Linde,Dominique A. Caugant,Hilde Kløvstad,Beata Młynarczyk-Bonikowska,Maria José Borrego,Peter Pavlik,Irena Klavs,T. Kustec,Julio A. Vázquez,Asunción Reynoso Díaz,Raquel Abad Torreblanca,Inga Velicko,Magnus Unemo,Helen Fifer,Kate Templeton +59 more
TL;DR: Agar dilution and minimum inhibitory concentration (MIC) gradient strip methodologies were used to determine the antimicrobial susceptibility (using EUCAST clinical breakpoints, where available) of 3239 N. gonorrhoeae isolates from 26 countries across the EU/EEA as mentioned in this paper .